2nd Quarter - Report

PURDUE PHARMA, LP for PURDUE PHARMA LP

Firm
Client
Income
—
Expenses
$198,400
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.

LobbyistCovered position, as disclosed
KATHLEEN KONKA New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2096 (117th), H.R. 1319 (117th), H.R. 1384 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.